Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02446353Phase 1Completed
Phase 1, randomised, open-label trial of megestrol in anorexia nervosa (AN) and cachexia (4 arms), sponsored by LG Chem. Primary endpoints: Maximum Plasma Concentration at 120 hours and Area Under the Curve to Last Measurable Concentration at 120 hours. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02446353.